FDA GFI, CDER Program for the Recognition of Voluntary Consensus Standards Related to Pharmaceutical Quality, 07/23 Anastasija Eschricht2023-08-17T08:20:19+00:00August 17th, 2023|
FDA GFI, Identification of Medicinal Products – Implementation and Use, 03/23 Anastasija Eschricht2023-07-24T13:44:30+00:00July 24th, 2023|
FDA GFI, Generally Accepted Scientific Knowledge in Applications for Drug and Biological Products: Nonclinical Information, DRAFT, 05/23 Anastasija Eschricht2023-06-27T09:47:42+00:00June 27th, 2023|
FDA GFI, Content of Human Factors Information in Medical Device Marketing Submissions, DRAFT, 12/22 Anastasija Eschricht2023-02-24T09:18:26+00:00February 24th, 2023|
FDA GFI, Best Practices for Communication Between IND Sponsors and FDA During Drug Development, 12/17 Anastasija Eschricht2023-02-24T09:13:59+00:00February 24th, 2023|
ICH Guideline Continuous Manufacturing of Drug Substances and Drug Products Q13, 11/22 Anastasija Eschricht2023-02-24T09:11:24+00:00February 24th, 2023|
